World's Best Scientists 2026 revealed!
Suzanne R. Hayman

Suzanne R. Hayman

D-Index & Metrics

Medicine

D-Index
95
Citations
33882
World Ranking
10061
National Ranking
5180

Overview

Suzanne R. Hayman is affiliated with the Mayo Clinic in the United States and has an extensive publication record in the fields of medicine and biochemistry, genetics, and molecular biology. Their work predominantly focuses on hematology, molecular biology, oncology, genetics, and immunology.

The scientist has made significant contributions to multiple areas of study, including multiple myeloma research and treatments, amyloidosis diagnosis and treatment, protein degradation and inhibitors, CAR-T cell therapy, chronic lymphocytic leukemia research, peptidase inhibition and analysis, as well as myeloproliferative neoplasms diagnosis and treatment.

Frequent co-authors working alongside Suzanne R. Hayman include Prashant Kapoor, Rahma Warsame, Taxiarchis Kourelis, David Dingli, and Shaji Kumar. This collaboration network highlights a strong connection within the hematological oncology research community.

The scientist's frequent publication venues demonstrate a focus on high-impact journals related to blood diseases and oncology. These venues include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Cancer Journal
  • Journal of Clinical Oncology
  • Leukemia

Among their recent published papers are:

  • "Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response" (2020, Blood Cancer Journal)
  • "Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities" (2020, Blood Advances)
  • "Mortality trends in multiple myeloma after the introduction of novel therapies in the United States" (2021, Leukemia)
  • "A simple additive staging system for newly diagnosed multiple myeloma" (2022, Blood Cancer Journal)
  • "Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update" (2021, Mayo Clinic Proceedings)

Best Publications

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

    S. Vincent Rajkumar;Suzanne Hayman;Morie A. Gertz;Angela Dispenzieri

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.

    S Kumar;A Dispenzieri;M Q Lacy;S R Hayman

  • The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

    Angela Dispenzieri;Martha Q. Lacy;Steven R. Zeldenrust;Suzanne R. Hayman

  • Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

    John A. Lust;Martha Q. Lacy;Steven R. Zeldenrust;Angela Dispenzieri

  • Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.

    Eli Muchtar;Morie A. Gertz;Shaji K. Kumar;Martha Q. Lacy

  • Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Martha Q. Lacy;Jerry A. Katzmann;S. Vincent Rajkumar

  • Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma

    Martha Q. Lacy;Angela Dispenzieri;Morie A. Gertz;Philip R. Greipp

  • Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;Terry M. Therneau

  • Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.

    Martha Q. Lacy;Jacob B. Allred;Morie A. Gertz;Suzanne R. Hayman

  • Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

    Shaji Kumar;Rafael Fonseca;Rhett P. Ketterling;Angela Dispenzieri

  • A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

    A K Stewart;P L Bergsagel;P R Greipp;A Dispenzieri

  • Hypertension in pregnancy: an emerging risk factor for cardiovascular disease

    Vesna D Garovic;Suzanne R Hayman

  • Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

    N. Leung;M.A. Gertz;S.R. Zeldenrust;S.V. Rajkumar

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

Morie A. Gertz
Morie A. Gertz Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Shaji Kumar
Shaji Kumar Mayo Clinic
Francis K. Buadi
Francis K. Buadi Mayo Clinic
David Dingli
David Dingli Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
Robert A. Kyle
Robert A. Kyle Mayo Clinic
John A. Lust
John A. Lust Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if medical school is your only option? There are flexible online degrees that pave the way to rewarding medical careers. For those considering practical roles in patient care, nursing school online provides a convenient and cost-effective way to enter the nursing field while balancing life's demands.

If you already hold an RN license, consider advancing your education through one of the cheapest online bsn programs. Earning a BSN opens doors to higher-level nursing roles and increased earning potential.

Interested in leadership or research? online phd nursing programs enable experienced nurses to shape healthcare policy or teach the next generation.

Even if you don’t have a nursing background, there are online msn programs for non nurses. These programs offer fast-track entry into advanced nursing roles for career changers.

Each of these pathways offers flexible online options that can help you start or advance a meaningful healthcare career—without attending traditional on-campus programs.

Best Scientists Citing Suzanne R. Hayman

Trending Scientists